<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-429" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Chloracne</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Schlessinger</surname>
            <given-names>Daniel I.</given-names>
          </name>
          <aff>Massachusetts General Hospital</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Robinson</surname>
            <given-names>Carolyn A.</given-names>
          </name>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Schlessinger</surname>
            <given-names>Joel</given-names>
          </name>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Daniel Schlessinger declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Carolyn Robinson declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Joel Schlessinger declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>17</day>
          <month>10</month>
          <year>2022</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-429.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Chloracne is an uncommon acneiform dermatosis caused by exposure to halogenated aromatic compounds. It represents a hallmark cutaneous manifestation of systemic toxicity. The malar cheeks, postauricular skin, axillae, and groin are commonly affected areas. Severity follows a typical dose-response relationship curve. This activity reviews the presentation, evaluation, and management of chloracne and highlights the role of an interprofessional team approach to the care of affected patients.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Identify&#x000a0;the etiology of chloracne.</p></list-item><list-item><p>Assess&#x000a0;the appearance and classical distribution of chloracne.</p></list-item><list-item><p>Determine&#x000a0;the treatment of chloracne.</p></list-item><list-item><p>Strategize care coordination strategies among the interprofessional team to optimize outcomes for patients affected by chloracne.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=429&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=429">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-429.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Chloracne is an acneiform eruption caused by exposure to halogenated aromatic compounds. Dioxin is recognized as the most significant environmental chloracnegen,<xref ref-type="bibr" rid="article-429.r1">[1]</xref><xref ref-type="bibr" rid="article-429.r2">[2]</xref>&#x000a0;but several are known as endocrine-disrupting compounds (EDCs), such as&#x000a0;polychlorinated biphenyls (PCBs).<xref ref-type="bibr" rid="article-429.r3">[3]</xref> Agent Orange is an infamous defoliant employed in the Vietnam War known to include traces of dioxin. Typical lesions include cysts, nodules, pustules, and open and closed comedones. The malar cheeks, postauricular skin, axillae, and groin are classically affected areas.<xref ref-type="bibr" rid="article-429.r2">[2]</xref> Severity follows a typical dose-response relationship curve; there may be multisystem impairment of the eyes, liver, endocrine, and nervous systems with high-level exposure. Chloracne is also known as metabolizing acquired dioxin-induced skin hamartomas (MADISH).<xref ref-type="bibr" rid="article-429.r4">[4]</xref></p>
      </sec>
      <sec id="article-429.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>Chloracnegens are fat-soluble and persist in the body fat and skin for a long period after&#x000a0;exposure. Routes of exposure include direct skin contact, ingestion, and inhalation. Most cases are related to occupational<xref ref-type="bibr" rid="article-429.r5">[5]</xref> or accidental exposure; however, the poisoning of Ukrainian President Victor Yushchenko is a notable case involving purposeful poisoning using dioxin.&#x000a0;</p>
        <p>Chloracne is caused by exposure to halogenated aromatic hydrocarbons found in:</p>
        <list list-type="bullet">
          <list-item>
            <p>Fungicides</p>
          </list-item>
          <list-item>
            <p>Herbicides</p>
          </list-item>
          <list-item>
            <p>Insecticides</p>
          </list-item>
          <list-item>
            <p>Wood preservatives</p>
          </list-item>
        </list>
        <p>Chemicals responsible for inducing chloracne include:</p>
        <list list-type="bullet">
          <list-item>
            <p>Chlornaphthalene</p>
          </list-item>
          <list-item>
            <p>Chlorobenzene</p>
          </list-item>
          <list-item>
            <p>PCBs</p>
          </list-item>
          <list-item>
            <p>Polychlorinated dibenzo-p-dioxins (PCDDs)</p>
          </list-item>
          <list-item>
            <p>Polychlorinated dibenzofurans (PCDFs)</p>
          </list-item>
          <list-item>
            <p>Pyrazole derivatives</p>
          </list-item>
          <list-item>
            <p>Chlorophenol contaminants</p>
          </list-item>
          <list-item>
            <p>Trifluoromethyl</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-429.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>Chloracne is a rare skin condition that is most often reported as a hazard of occupational exposure&#x000a0;and may be seen in&#x000a0;chemical production workers and those who handled, applied, or were exposed to 2,3,7,8-tetrachlorodibenzo-para-dioxin (TCDD)-contaminated pesticides.<xref ref-type="bibr" rid="article-429.r5">[5]</xref> Outbreaks have occurred with accidental mass exposures, and at least&#x000a0;1 well-known individual has been targeted by poisoning. The first documented human exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin (2,3,7,8-TCDD)-contaminated chemicals was reported in 1949 after a trichlorophenol reactor exploded in Nitro, West Virginia, communities have been affected by contaminated oil in Missouri and industrial waste in Seveso, Italy.<xref ref-type="bibr" rid="article-429.r6">[6]</xref>&#x000a0;The largest reported incident occurred in Japan in 1968, involving approximately 1600 victims.<xref ref-type="bibr" rid="article-429.r2">[2]</xref> During the Vietnam War, Agent Orange was used widely, but the true prevalence of chloracne in Vietnam veterans is not known. Today, the use of polyhydrocarbons&#x000a0;containing dioxin is restricted.<xref ref-type="bibr" rid="article-429.r7">[7]</xref></p>
      </sec>
      <sec id="article-429.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>Chloracne is an acne-like condition due to the persistence of toxic chemicals and their metabolites. Toxins accumulate within the sebaceous glands and alter their normal physiology from oil-producing glands into chloracne's cyst-like structures (hamartomas).<xref ref-type="bibr" rid="article-429.r8">[8]</xref>&#x000a0;These changes occur through activating the aryl hydrocarbon receptor (AHR), expressed in keratinocytes and sebocytes, accelerating epidermal terminal differentiation (keratinization), and converting sebocytes toward keratinocyte differentiation.<xref ref-type="bibr" rid="article-429.r9">[9]</xref><xref ref-type="bibr" rid="article-429.r10">[10]</xref>&#x000a0;Specimens from the epidermis and cyst epithelium of MADISH patients demonstrate a strong expression of small proline-rich protein 2 (SPRR2), secretory leukocyte peptidase inhibitor (SLPI), epigen (EPGN), and the nuclear factor erythroid-derived 2 like 2 (NRF2) target NAD(P)H dehydrogenase, quinone 1 (NQO1).<xref ref-type="bibr" rid="article-429.r11">[11]</xref></p>
        <p>Systemically, chloracnegens can act as EDCs, in which they behave like other endogenous hormones such as&#x000a0;estrogens, progesterone, and androgens. They can also manipulate numerous receptors, like those related to retinoids or&#x000a0;aryl hydrocarbons, resulting in overactivation and perturbations of the normal metabolic pathways. As a result, EDCs can lead to thyroid dysfunction, reproductive issues (cryptorchidism, hypospadias, testicular cancer, and female precocious puberty),&#x000a0;leukemia, brain tumors, neurobehavioral disorders, type 2 diabetes, and obesity.<xref ref-type="bibr" rid="article-429.r3">[3]</xref></p>
      </sec>
      <sec id="article-429.s6" sec-type="Histopathology">
        <title>Histopathology</title>
        <p>The glaring lack of sebaceous glands is the most distinguishing histopathologic feature of chloracne.<xref ref-type="bibr" rid="article-429.r4">[4]</xref>&#x000a0;There are often epidermal cysts that may be superficial with an open punctum or dermal cysts.</p>
      </sec>
      <sec id="article-429.s7" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>The course of systemic symptoms and skin changes varies based on the duration and level of toxic exposure. If massive exposure occurs, symptoms may appear within days.&#x000a0;Chloracne lesions may not appear for weeks to months after exposure.</p>
        <p>Acute, high-level exposure to halogenated aromatic compounds may cause the following systemic symptoms:</p>
        <list list-type="bullet">
          <list-item>
            <p>Gastrointestinal distress (nausea, vomiting, diarrhea)</p>
          </list-item>
          <list-item>
            <p>Liver dysfunction</p>
          </list-item>
          <list-item>
            <p>Pancreatitis</p>
          </list-item>
          <list-item>
            <p>Neuropathy</p>
          </list-item>
          <list-item>
            <p>Joint pain</p>
          </list-item>
        </list>
        <p>Skin lesions appear on the cheeks and postauricular skin and may progress into the axillae and groin. They may also involve the shoulders, chest, back, and abdomen or, in very advanced cases, extend to the extremities. The skin may first appear excessively oily before the typical lesions of chloracne arise, including:</p>
        <list list-type="bullet">
          <list-item>
            <p>Open and closed comedones (blackheads and whiteheads)</p>
          </list-item>
          <list-item>
            <p>Nodules and cysts</p>
          </list-item>
          <list-item>
            <p>Pustules</p>
          </list-item>
        </list>
        <p>Other cutaneous and mucosal problems seen with chloracne include:</p>
        <list list-type="bullet">
          <list-item>
            <p>Palmar or plantar hyperhidrosis (excessive sweating of the&#x000a0;palms and/or soles)</p>
          </list-item>
          <list-item>
            <p>Porphyria cutanea tarda (pigmentation, increased hair growth, and blisters on exposed skin)&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Hypertrichosis of body hair</p>
          </list-item>
          <list-item>
            <p>Hyperpigmentation of skin, hair, or nails</p>
          </list-item>
          <list-item>
            <p>Conjunctivitis, hyperpigmentation of the conjunctival mucosa, and enlargement of meibomian glands&#x000a0;<xref ref-type="bibr" rid="article-429.r2">[2]</xref><xref ref-type="bibr" rid="article-429.r12">[12]</xref><xref ref-type="bibr" rid="article-429.r2">[2]</xref></p>
          </list-item>
        </list>
      </sec>
      <sec id="article-429.s8" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>A targeted history and physical exam are vital for a correct diagnosis. Toxicologic screenings for halogenated aromatic hydrocarbons may be performed, but there is conflicting evidence regarding their reliability. In the past, polyhydrocarbons were routinely measured in the blood and urine. In a group of individuals exposed to 2,3,7,8-TCDD, chloracne,&#x000a0;gamma-glutamyl transferase elevations, and triglycerides, alterations in&#x000a0;follicular stimulating hormone&#x000a0;and&#x000a0;luteinizing hormone correlated to serum 2,3,7,8-TCDD levels.<xref ref-type="bibr" rid="article-429.r6">[6]</xref>&#x000a0;However, due to differences in individual sensitivities to dioxin and its related chemicals, and because these substances can be concentrated within adipose and skin structures, it is challenging to diagnose chloracne solely based on&#x000a0;serum toxic equivalent values.<xref ref-type="bibr" rid="article-429.r4">[4]</xref></p>
        <p>Biopsies of affected skin may show a reduction of the normal sebaceous gland density and skin hamartomas. Immunohistochemistry can be carried out on biopsy specimens to assess the gene expression (ie, CYP1A1).<xref ref-type="bibr" rid="article-429.r13">[13]</xref></p>
      </sec>
      <sec id="article-429.s9" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>Once chloracne is diagnosed, the primary action is to prevent further exposure to the chemical source, which, in many cases, improves the lesions. If lesions persist for a long time despite eliminating further toxin exposure, treatments for acne vulgaris, such as topical retinoids, oral antibiotics, or isotretinoin, may be considered. Comedones may be expressed, and cysts may be excised. Recently, a small cohort of Japanese patients with dioxin-related sequelae for 30&#x000a0;to 40 years was treated orally with&#x000a0;a cinnamaldehyde-containing&#x000a0;antioxidant called&#x000a0;<italic toggle="yes">Keishibukuryogan.&#x000a0;</italic>Treatment with this herbal medicine, which&#x000a0;exhibits&#x000a0;aryl hydrocarbon receptor (AHR)&#x02013;cytochrome P450 family 1 subfamily A member 1 (CYP1A1) inhibition and nuclear factor erythroid 2 p45-related factor 2 (NRF2) activation, improved the patient's chloracne and associated systemic symptoms.<xref ref-type="bibr" rid="article-429.r14">[14]</xref>&#x000a0;Patients with chloracnegen exposure history&#x000a0;must be followed longitudinally because the toxic exposure may also impact other organs than the skin and may be linked to various malignancies.</p>
      </sec>
      <sec id="article-429.s10" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>The differential diagnoses for&#x000a0;chloracne&#x000a0;include the following:</p>
        <list list-type="bullet">
          <list-item>
            <p>Acne vulgaris</p>
          </list-item>
          <list-item>
            <p>Favre-Racouchot syndrome (also known as solar or senile comedones and nodular elastosis with cysts and comedones)</p>
          </list-item>
          <list-item>
            <p>Folliculitis</p>
          </list-item>
          <list-item>
            <p>Dilated pore of Winer</p>
          </list-item>
          <list-item>
            <p>Epidermal inclusion cyst</p>
          </list-item>
          <list-item>
            <p>Milia</p>
          </list-item>
          <list-item>
            <p>Folliculotropic mycosis fungoides</p>
          </list-item>
          <list-item>
            <p>Nevus comedonicus</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-429.s11" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>The severity and duration of chloracne lesions correlate to toxin exposure time and levels. Once the exposure has been isolated and removed, lesions generally improve without further intervention, although this may take years.</p>
      </sec>
      <sec id="article-429.s12" sec-type="Complications">
        <title>Complications</title>
        <p>Chloracne is associated with a variable amount of permanent scarring. Lesions on the malar cheeks and postauricular skin tend to persist longer than those localized elsewhere on the body.<xref ref-type="bibr" rid="article-429.r2">[2]</xref>&#x000a0;</p>
        <p>Immunotoxicity, namely immunosuppression<xref ref-type="bibr" rid="article-429.r15">[15]</xref>, and developmental effects may occur over long periods of exposure to dioxin and dioxin-like compounds.<xref ref-type="bibr" rid="article-429.r16">[16]</xref>&#x000a0;Malignancies linked to chloracnegen exposure include non-Hodgkin lymphoma, soft-tissue sarcomas (such as dermatofibrosarcoma protuberans, and leiomyosarcomas)<xref ref-type="bibr" rid="article-429.r17">[17]</xref>, and&#x000a0;nonmelanoma skin cancer.<xref ref-type="bibr" rid="article-429.r18">[18]</xref></p>
      </sec>
      <sec id="article-429.s13" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Patients with occupational risk factors such as exposure to&#x000a0;herbicides, insecticides, fungicides, wood treatments, or those who may have been exposed to Agent Orange should be counseled on systemic and cutaneous signs and symptoms associated with chloracne. The data for an association with other health problems, such as congenital anomalies, are conflicting;<xref ref-type="bibr" rid="article-429.r2">[2]</xref> however, educating both partners on the potential for congenital anomalies would be prudent.&#x000a0;Patients can be reassured that, in most cases,&#x000a0;lesions and systemic symptoms tend to spontaneously improve slowly over time once there is no further chemical exposure.</p>
      </sec>
      <sec id="article-429.s14" sec-type="Pearls and Other Issues">
        <title>Pearls and Other Issues</title>
        <p>Other health problems associated with chloracne&#x000a0;include:</p>
        <list list-type="bullet">
          <list-item>
            <p>Abnormal liver function</p>
          </list-item>
          <list-item>
            <p>Fatigue and sleep disturbance</p>
          </list-item>
          <list-item>
            <p>Transient peripheral neuropathy</p>
          </list-item>
          <list-item>
            <p>Encephalopathy, leading to poor concentration or depression</p>
          </list-item>
          <list-item>
            <p>Hyperlipidemia (particularly increased triglycerides)&#x000a0;<xref ref-type="bibr" rid="article-429.r2">[2]</xref></p>
          </list-item>
          <list-item>
            <p>Impotence</p>
          </list-item>
          <list-item>
            <p>Type 2 diabetes</p>
          </list-item>
        </list>
        <p>Patients should undergo regular full-body skin exams and blood work, including a complete blood count with differential, liver function tests, hemoglobin A1c, and serum cholesterol, to monitor for cutaneous malignancies, lymphoma, liver dysfunction, type 2 diabetes, and hyperlipidemia.</p>
      </sec>
      <sec id="article-429.s15" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Chloracne is a rare skin disorder, but when it presents itself, it is best managed by an interprofessional team that includes poison control, a dermatologist, a biohazard expert, and an internist. The source must be identified rapidly to help minimize a public health disaster. Chloracne is the hallmark cutaneous feature and may best be treated by a dermatologist when recalcitrant.&#x000a0;However, regular physicals and blood work monitoring should be carried out by an internist to identify other possible systemic sequelae.</p>
      </sec>
      <sec id="article-429.s16">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=429&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=429">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/wilderness-and-environmental/chloracne-metabolizing-acquired-dioxin-induced-skin-hamartomas-madish/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=429">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/429/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=429">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-429.s17">
        <title>References</title>
        <ref id="article-429.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ju</surname>
                <given-names>Q</given-names>
              </name>
              <name>
                <surname>Zouboulis</surname>
                <given-names>CC</given-names>
              </name>
              <name>
                <surname>Xia</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Environmental pollution and acne: Chloracne.</article-title>
            <source>Dermatoendocrinol</source>
            <year>2009</year>
            <month>May</month>
            <volume>1</volume>
            <issue>3</issue>
            <fpage>125</fpage>
            <page-range>125-8</page-range>
            <pub-id pub-id-type="pmid">20436879</pub-id>
          </element-citation>
        </ref>
        <ref id="article-429.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tindall</surname>
                <given-names>JP</given-names>
              </name>
            </person-group>
            <article-title>Chloracne and chloracnegens.</article-title>
            <source>J Am Acad Dermatol</source>
            <year>1985</year>
            <month>Oct</month>
            <volume>13</volume>
            <issue>4</issue>
            <fpage>539</fpage>
            <page-range>539-58</page-range>
            <pub-id pub-id-type="pmid">2934435</pub-id>
          </element-citation>
        </ref>
        <ref id="article-429.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ju</surname>
                <given-names>Q</given-names>
              </name>
              <name>
                <surname>Zouboulis</surname>
                <given-names>CC</given-names>
              </name>
            </person-group>
            <article-title>Endocrine-disrupting chemicals and skin manifestations.</article-title>
            <source>Rev Endocr Metab Disord</source>
            <year>2016</year>
            <month>Sep</month>
            <volume>17</volume>
            <issue>3</issue>
            <fpage>449</fpage>
            <page-range>449-457</page-range>
            <pub-id pub-id-type="pmid">27363826</pub-id>
          </element-citation>
        </ref>
        <ref id="article-429.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Saurat</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>Sorg</surname>
                <given-names>O</given-names>
              </name>
            </person-group>
            <article-title>Chloracne, a misnomer and its implications.</article-title>
            <source>Dermatology</source>
            <year>2010</year>
            <month>Aug</month>
            <volume>221</volume>
            <issue>1</issue>
            <fpage>23</fpage>
            <page-range>23-6</page-range>
            <pub-id pub-id-type="pmid">20431274</pub-id>
          </element-citation>
        </ref>
        <ref id="article-429.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Alchorne</surname>
                <given-names>Ade O</given-names>
              </name>
              <name>
                <surname>Alchorne</surname>
                <given-names>MM</given-names>
              </name>
              <name>
                <surname>Silva</surname>
                <given-names>MM</given-names>
              </name>
            </person-group>
            <article-title>Occupational dermatosis.</article-title>
            <source>An Bras Dermatol</source>
            <year>2010</year>
            <season>Mar-Apr</season>
            <volume>85</volume>
            <issue>2</issue>
            <fpage>137</fpage>
            <page-range>137-45; quiz 146-7</page-range>
            <pub-id pub-id-type="pmid">20520928</pub-id>
          </element-citation>
        </ref>
        <ref id="article-429.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sweeney</surname>
                <given-names>MH</given-names>
              </name>
              <name>
                <surname>Mocarelli</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Human health effects after exposure to 2,3,7,8-TCDD.</article-title>
            <source>Food Addit Contam</source>
            <year>2000</year>
            <month>Apr</month>
            <volume>17</volume>
            <issue>4</issue>
            <fpage>303</fpage>
            <page-range>303-16</page-range>
            <pub-id pub-id-type="pmid">10912244</pub-id>
          </element-citation>
        </ref>
        <ref id="article-429.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tavakoly Sany</surname>
                <given-names>SB</given-names>
              </name>
              <name>
                <surname>Hashim</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Salleh</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Rezayi</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Karlen</surname>
                <given-names>DJ</given-names>
              </name>
              <name>
                <surname>Razavizadeh</surname>
                <given-names>BB</given-names>
              </name>
              <name>
                <surname>Abouzari-Lotf</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Dioxin risk assessment: mechanisms of action and possible toxicity in human health.</article-title>
            <source>Environ Sci Pollut Res Int</source>
            <year>2015</year>
            <month>Dec</month>
            <volume>22</volume>
            <issue>24</issue>
            <fpage>19434</fpage>
            <page-range>19434-50</page-range>
            <pub-id pub-id-type="pmid">26514567</pub-id>
          </element-citation>
        </ref>
        <ref id="article-429.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bock</surname>
                <given-names>KW</given-names>
              </name>
            </person-group>
            <article-title>From dioxin toxicity to putative physiologic functions of the human Ah receptor in homeostasis of stem/progenitor cells.</article-title>
            <source>Biochem Pharmacol</source>
            <year>2017</year>
            <month>Jan</month>
            <day>01</day>
            <volume>123</volume>
            <fpage>1</fpage>
            <page-range>1-7</page-range>
            <pub-id pub-id-type="pmid">27349986</pub-id>
          </element-citation>
        </ref>
        <ref id="article-429.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Furue</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Tsuji</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Chloracne and Hyperpigmentation Caused by Exposure to Hazardous Aryl Hydrocarbon Receptor Ligands.</article-title>
            <source>Int J Environ Res Public Health</source>
            <year>2019</year>
            <month>Dec</month>
            <day>03</day>
            <volume>16</volume>
            <issue>23</issue>
            <pub-id pub-id-type="pmid">31816860</pub-id>
          </element-citation>
        </ref>
        <ref id="article-429.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bock</surname>
                <given-names>KW</given-names>
              </name>
            </person-group>
            <article-title>Toward elucidation of dioxin-mediated chloracne and Ah receptor functions.</article-title>
            <source>Biochem Pharmacol</source>
            <year>2016</year>
            <month>Jul</month>
            <day>15</day>
            <volume>112</volume>
            <fpage>1</fpage>
            <page-range>1-5</page-range>
            <pub-id pub-id-type="pmid">26801687</pub-id>
          </element-citation>
        </ref>
        <ref id="article-429.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sch&#x000e4;fer</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Willrodt</surname>
                <given-names>AH</given-names>
              </name>
              <name>
                <surname>Kurinna</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Link</surname>
                <given-names>AS</given-names>
              </name>
              <name>
                <surname>Farwanah</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Geusau</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Gruber</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Sorg</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Huebner</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Roop</surname>
                <given-names>DR</given-names>
              </name>
              <name>
                <surname>Sandhoff</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Saurat</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>Tschachler</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Schneider</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>Langbein</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Bloch</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Beer</surname>
                <given-names>HD</given-names>
              </name>
              <name>
                <surname>Werner</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Activation of Nrf2 in keratinocytes causes chloracne (MADISH)-like skin disease in mice.</article-title>
            <source>EMBO Mol Med</source>
            <year>2014</year>
            <month>Apr</month>
            <volume>6</volume>
            <issue>4</issue>
            <fpage>442</fpage>
            <page-range>442-57</page-range>
            <pub-id pub-id-type="pmid">24503019</pub-id>
          </element-citation>
        </ref>
        <ref id="article-429.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kushwaha</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Kumar</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Kulkarni</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Ghorpade</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Chloracne in a Farming Family.</article-title>
            <source>Skinmed</source>
            <year>2017</year>
            <volume>15</volume>
            <issue>6</issue>
            <fpage>485</fpage>
            <page-range>485-488</page-range>
            <pub-id pub-id-type="pmid">29282195</pub-id>
          </element-citation>
        </ref>
        <ref id="article-429.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fontao</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Barnes</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Kaya</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Saurat</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>Sorg</surname>
                <given-names>O</given-names>
              </name>
            </person-group>
            <article-title>From the Cover: High Susceptibility of Lrig1 Sebaceous Stem Cells to TCDD in Mice.</article-title>
            <source>Toxicol Sci</source>
            <year>2017</year>
            <month>Dec</month>
            <day>01</day>
            <volume>160</volume>
            <issue>2</issue>
            <fpage>230</fpage>
            <page-range>230-243</page-range>
            <pub-id pub-id-type="pmid">28973660</pub-id>
          </element-citation>
        </ref>
        <ref id="article-429.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Furue</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Fuyuno</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Mitoma</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Uchi</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Tsuji</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Therapeutic Agents with AHR Inhibiting and NRF2 Activating Activity for Managing Chloracne.</article-title>
            <source>Antioxidants (Basel)</source>
            <year>2018</year>
            <month>Jul</month>
            <day>13</day>
            <volume>7</volume>
            <issue>7</issue>
            <pub-id pub-id-type="pmid">30011787</pub-id>
          </element-citation>
        </ref>
        <ref id="article-429.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Du</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Zhao</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Ji</surname>
                <given-names>HC</given-names>
              </name>
              <name>
                <surname>Luo</surname>
                <given-names>YB</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Mao</surname>
                <given-names>GH</given-names>
              </name>
              <name>
                <surname>Feng</surname>
                <given-names>WW</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Wu</surname>
                <given-names>XY</given-names>
              </name>
              <name>
                <surname>Yang</surname>
                <given-names>LQ</given-names>
              </name>
            </person-group>
            <article-title>Dioxin-like (DL-) polychlorinated biphenyls induced immunotoxicity through apoptosis in mice splenocytes via the AhR mediated mitochondria dependent signaling pathways.</article-title>
            <source>Food Chem Toxicol</source>
            <year>2019</year>
            <month>Dec</month>
            <volume>134</volume>
            <fpage>110803</fpage>
            <pub-id pub-id-type="pmid">31563530</pub-id>
          </element-citation>
        </ref>
        <ref id="article-429.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Malisch</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Denison</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>Fiedler</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>F&#x000fc;rst</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Hoogenboom</surname>
                <given-names>RLAP</given-names>
              </name>
              <name>
                <surname>Schaechtele</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Schrenk</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>van den Berg</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Do PCDD/PCDF standard solutions used in dioxin analysis pose a risk as potentially acutely toxic to lab personnel?</article-title>
            <source>Chemosphere</source>
            <year>2017</year>
            <month>Oct</month>
            <volume>185</volume>
            <fpage>489</fpage>
            <page-range>489-498</page-range>
            <pub-id pub-id-type="pmid">28715759</pub-id>
          </element-citation>
        </ref>
        <ref id="article-429.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Patterson</surname>
                <given-names>AT</given-names>
              </name>
              <name>
                <surname>Kaffenberger</surname>
                <given-names>BH</given-names>
              </name>
              <name>
                <surname>Keller</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Elston</surname>
                <given-names>DM</given-names>
              </name>
            </person-group>
            <article-title>Skin diseases associated with Agent Orange and other organochlorine exposures.</article-title>
            <source>J Am Acad Dermatol</source>
            <year>2016</year>
            <month>Jan</month>
            <volume>74</volume>
            <issue>1</issue>
            <fpage>143</fpage>
            <page-range>143-70</page-range>
            <pub-id pub-id-type="pmid">26210237</pub-id>
          </element-citation>
        </ref>
        <ref id="article-429.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Clemens</surname>
                <given-names>MW</given-names>
              </name>
              <name>
                <surname>Kochuba</surname>
                <given-names>AL</given-names>
              </name>
              <name>
                <surname>Carter</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>Han</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Evans</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Association between Agent Orange exposure and nonmelanotic invasive skin cancer: a pilot study.</article-title>
            <source>Plast Reconstr Surg</source>
            <year>2014</year>
            <month>Feb</month>
            <volume>133</volume>
            <issue>2</issue>
            <fpage>432</fpage>
            <page-range>432-437</page-range>
            <pub-id pub-id-type="pmid">24469173</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
